Child Mortality clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Infant Mortality Reduction by the Mass Administration of Azithromycin
Sorry, not currently recruiting here
This trial will investigate the supplementation of azithromycin distribution to the "Child Health Days" platform in Burkina Faso for child mortality reduction. This distribution will pair door-to-door administration of vitamin A and azithromycin or placebo with acute malnutrition screening among children 1-11 months old.
San Francisco, California and other locations
Our lead scientists for Child Mortality research studies include Thomas Lietman, MD.
Last updated: